[Bilateral optic neuropathy revealing systemic sarcoidosis]

Rev Med Interne. 2004 Oct;25(10):755-8. doi: 10.1016/j.revmed.2004.07.002.
[Article in French]

Abstract

Introduction: Although ocular involvement concerns about 25 to 60% of patients with systemic sarcoidosis, papilledema is a rare event.

Exegesis: A 43-year-old man presented with left visual loss related to papillitis. Despite high-dose corticosteroids, visual loss became rapidly bilateral. Thoracic CT-scan showed mediastinal and parenchymal involvement. Histological study of lung, bronchial and lymphadenopathy biopsies displayed giant-cells granuloma without necrosis. Diagnosis of sarcoidosis complicated with optic neuropathy was made. Therapy combining prednisone, methotrexate and infliximab was started without significant improvement of visual acuity.

Conclusion: This report underlines the potential severity of optic neuropathy in sarcoidosis.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use
  • Blindness / etiology*
  • Diabetes Mellitus, Type 1 / complications
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use
  • Optic Atrophy / diagnosis
  • Optic Atrophy / etiology
  • Optic Nerve Diseases / diagnosis
  • Optic Nerve Diseases / etiology*
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use
  • Sarcoidosis / complications*
  • Sarcoidosis / diagnosis
  • Sarcoidosis / drug therapy
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Infliximab
  • Prednisone
  • Methotrexate